🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

3,061 results for “Bio” Clear

  1. Randomized, open-label, single dose, two-period, two-treatment, cross-over bioequivalence study comparing test product Rivaroxaban/Acetylsalicylic acid, tablet, 2.5 mg/50 mg (given as two tablets) to reference product Xarelto 2.5 mg film-coated tablets (given as two tablets) and Aspirin® N 100 mg tablet in healthy male and female subjects under fasting conditions.

    Lacuna Pharma Pty Ltd

    not applicable (submitted trial is a bioequivalence in healthy subjects)

    phase 1 other active

    1 trial

  2. Randomized, open-label, single-dose, two-period, cross-over, bioequivalence study comparing Linagliptin 5 mg film-coated tablets (Vipharm S.A.) to Trajenta® 5 mg film-coated tablets (Boehringer Ingelheim) in healthy volunteers under fasting conditions.

    Alphapharm Pty Ltd

    Bioequivalence study in healthy volunteers under fasting conditions

    phase 1 other active

    1 trial

  3. Ranolazine

    BRIGHT MINDS BIOSCIENCES INC.

    Drug-induced QT Prolongation

    phase 1 small molecule completed

    1 trial

  4. Reference, Patch location thigh, batch 1

    BRIGHT MINDS BIOSCIENCES INC.

    Bioequivalence

    phase 1 small molecule completed

    1 trial

  5. Relative bioavailability and safety study of pasireotide after a single-dose subcutaneous administration in the arm or in the thigh compared to in the abdomen using a ServoPen in healthy subjects.

    Recordati Ireland

    Post-bariatric hypoglycaemia

    phase 1 other active

    1 trial

  6. Repetitive Transcranial Magnetic Stimulation

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Use

    phase 1 other terminated

    1 trial

  7. Research ENDS S-TA-U001

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking

    phase 1 small molecule completed

    1 trial

  8. Reserpine

    BRIGHT MINDS BIOSCIENCES INC.

    Amphetamine-Related Disorders

    phase 1 small molecule active

    1 trial

  9. Reslizumab IV

    Teva Pharma GmbH

    Absolute Bioavailability

    phase 1 small molecule completed

    1 trial

  10. Rose bengal disodium

    PROVECTUS BIOPHARMACEUTICALS, INC.

    Neuroendocrine Tumors Metastatic to the Liver

    phase 1 small molecule active

    1 trial

  11. SAB-176

    SAB Biotherapeutics

    Influenza Type A

    phase 1 mab completed

    1 trial

  12. SAB-185

    SAB Biotherapeutics

    COVID-19

    phase 1 mab active

    2 trials

  13. SAB-301

    SAB Biotherapeutics

    Middle East Respiratory Syndrome Coronavirus

    phase 1 mab completed

    1 trial

  14. SBP-9330

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    phase 1 small molecule completed

    1 trial

  15. SC262

    Sana Biotechnology

    Non Hodgkin's Lymphoma

    phase 1 small molecule active

    1 trial

  16. SC291

    Sana Biotechnology

    Lupus Erythematosus

    phase 1 mab active

    1 trial

  17. SC291

    Sana Biotechnology

    Non Hodgkin Lymphoma

    phase 1 small molecule active

    1 trial

  18. SGT-212

    Solid Biosciences

    Friedreich's Ataxia (FA)

    phase 1 small molecule active

    1 trial

  19. SGT-501

    Solid Biosciences

    Catecholaminergic Polymorphic Ventricular Tachycardia

    phase 1 small molecule active

    1 trial

  20. ST-2427

    BRIGHT MINDS BIOSCIENCES INC.

    Acute, Post-operative Pain

    phase 1 small molecule terminated

    1 trial

  21. ST1968

    BRIGHT MINDS BIOSCIENCES INC.

    Solid Tumors

    phase 1 small molecule completed

    1 trial

  22. STP7 (mavoglurant)

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Use Disorder

    phase 1 small molecule completed

    1 trial

  23. STP705

    BRIGHT MINDS BIOSCIENCES INC.

    Hepatocellular Carcinoma

    phase 1 small molecule completed

    1 trial

  24. STRO-001

    SUTRO BIOPHARMA, INC.

    B-cell Lymphoma

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources